What is the appropriate cefuroxime dosage per kilogram of body weight?

Cefuroxime Dosing Per Kilogram

For intravenous cefuroxime, use 50-100 mg/kg/day divided every 6-8 hours for most pediatric infections, 150 mg/kg/day for bone/joint infections, and 200-240 mg/kg/day for bacterial meningitis; for oral cefuroxime axetil, use 30 mg/kg/day divided twice daily. 1

Intravenous (IV) Cefuroxime Dosing

Pediatric Patients (>3 months)

Standard infections:

• 50-100 mg/kg/day divided every 6-8 hours 1
• Use the higher end (100 mg/kg/day, not exceeding maximum adult dosage) for severe or serious infections 1

Bone and joint infections:

• 150 mg/kg/day (not exceeding maximum adult dosage) divided every 8 hours 2, 1

Bacterial meningitis:

• 200-240 mg/kg/day IV divided every 6-8 hours 1
• This higher dose is critical for adequate CNS penetration 3

Alternative dosing from guidelines:

• 20-30 mg/kg every 8 hours (three times daily) for respiratory infections 4

Adult Dosing

• 750 mg to 1.5 grams every 8 hours 1
• For severe infections or less susceptible organisms: 1.5 grams every 6 hours 1
• Meningitis: up to 3 grams every 8 hours 1

Oral Cefuroxime Axetil Dosing

Pediatric Patients

Standard dosing:

• 30 mg/kg/day divided in 2 doses (maximum 500 mg per dose) 5
• Age-based: 125 mg twice daily (1-24 months); 250 mg twice daily (2-12 years) 4

Clinical evidence: Studies demonstrate 30 mg/kg/day in two divided doses achieves 94.2% bacteriological eradication for streptococcal pharyngitis 6 and comparable efficacy to amoxicillin-clavulanate for otitis media 7

Adult Dosing

• 500 mg twice daily for most infections 5
• 250 mg twice daily for uncomplicated infections 5

Key Clinical Considerations

Renal adjustment required: Reduce frequency when creatinine clearance <20 mL/min 1

Weight-based dosing advantage: Recent pharmacokinetic data confirms 20 mg/kg IV provides comparable tissue concentrations across weight ranges from 50-100 kg, supporting weight-based over fixed dosing 8

Pharmacodynamic targets: Cefuroxime requires time above MIC (T>MIC) of 40-50% for efficacy 9, 10. Standard dosing achieves this for MICs up to 0.5 mg/L for IV and 1.0 mg/L for oral formulations 9

Duration: Continue for minimum 48-72 hours after symptom resolution; 10 days minimum for Streptococcus pyogenes infections 1

Common pitfall: Do not use doses smaller than recommended - inadequate dosing risks treatment failure and resistance development 1